Search

Your search keyword '"Rohan A Gajjar"' showing total 6 results
Start Over Author "Rohan A Gajjar"
6 results on '"Rohan A Gajjar"'

1. Medicated adhesive dressing is a safe and non-inferior cutaneous seal as compared to compound tincture benzoin dermal seal for percutaneous interventions

Author

Rudradatt C Parmar, Dhruvkumar M Patel, Mukundkumar V Patel, Bhagirath B Solanki, Maitri M Patel, Jayanti K Gurumukhani, Himil J Mahadevia, Rohan A Gajjar, and Parth R Patel

Subjects
Compound tincture benzoin, cutaneous seal dressing, medicated adhesive dressing, non-inferior dressing material, percutaneous interventions, skin incision, Medicine
Abstract

Background: Compound tincture benzoin (CTB) is used as a post-procedure skin seal antiseptic agent since ancient times; but this drug is reported to cause allergic contact dermatitis and other unwanted side effects. Our aim of the present study was to compare alternative agent like Medicated Adhesive dressing (MAD) with CTB as a post-procedure skin seal dressing. Design: This prospective randomized controlled experimental study included an equal number of patients in MAD and CTB as a post-operative seal dressing material for percutaneous interventions. Both the groups were graded for various efficacy parameters like comfort, applicability, dressing material, and immediate post-operative complications by operating doctor and attending nurse with a maximum 10 points in each group. Results: 120 patients were studied in each MAD and CTB group. Out of total patients 31.25% were males and the mean age of the patient was 33.56 ± 11.10. Allergic contact dermatitis developed in 9 (7.49%) of CTB group and in 1 (0.83%) of MAD group (P < 0.002), while local site skin infections were noted in 8 (6.67%) of CTB group and in 1 (0.83%) of MAD (P < 0.002). Operating doctor graded MAD and CTB to 7.60 ± 0.49 and 3.62 ± 0.48 (P < 0.003); and attending nurse 7.40 ± 0.49 and 3.41 ± 0.49 (P < 0.003) respectively. Conclusion: MAD is a safe, efficient and non-inferior alternative dressing material for post-procedure skin incision seal in comparison to CTB.

Published
2019
Full Text
View/download PDF

5. A Rare Case of Herpes Zoster in an Adult Patient Recovered From Symptomatic Reinfection of COVID-19

Author

Dhigishaba M Jadeja, Rohan A Gajjar, Vaishnavi K Modi, and Binita Ghosh

Subjects
medicine.medical_specialty, Coronavirus disease 2019 (COVID-19), business.industry, medicine.medical_treatment, viruses, adult, General Engineering, Varicella zoster virus, virus diseases, Immunosuppression, herpes zoster, Immunosenescence, medicine.disease_cause, Dermatology, Natural history, sars-cov-2, Herpes simplex virus, covid-19, varicella zoster, Rare case, medicine, Internal Medicine, Risk factor, business
Abstract

In coronavirus disease 2019 (COVID-19) patients, various dermatological conditions have been observed. Varicella zoster virus (VZV) and herpes simplex virus must be ruled out before considering vesicular exanthems linked to COVID-19. The immunological status of the host has an impact on the natural history of herpes zoster (HZ). Age is a major risk factor for most of the cases of HZ. Reactivation of VZV can be triggered by iatrogenic immunosuppression or disease-related immunocompromised state or age-related immunosenescence. Rarely, dermatological symptoms have been reported in recovered COVID-19 patients. We hereby present a rare case of HZ in a recovered patient from symptomatic reinfection of COVID-19.

Published
2021

6. Medicated adhesive dressing is a safe and non-inferior cutaneous seal as compared to compound tincture benzoin dermal seal for percutaneous interventions

Author

Parth R Patel, Rudradatt C Parmar, Jayanti K Gurumukhani, Bhagirath B. Solanki, Maitri M Patel, Dhruvkumar M Patel, Rohan A Gajjar, Himil J Mahadevia, and Mukundkumar V Patel

Subjects
medicine.medical_specialty, Percutaneous, lcsh:Medicine, Antiseptic Agent, cutaneous seal dressing, Skin infection, Seal (mechanical), complex mixtures, chemistry.chemical_compound, Benzoin, Medicine, Allergic contact dermatitis, non-inferior dressing material, skin incision, medicated adhesive dressing, Skin incision, business.industry, lcsh:R, Tincture, percutaneous interventions, medicine.disease, Surgery, chemistry, Compound tincture benzoin, Original Article, business
Abstract

Background: Compound tincture benzoin (CTB) is used as a post-procedure skin seal antiseptic agent since ancient times; but this drug is reported to cause allergic contact dermatitis and other unwanted side effects. Our aim of the present study was to compare alternative agent like Medicated Adhesive dressing (MAD) with CTB as a post-procedure skin seal dressing. Design: This prospective randomized controlled experimental study included an equal number of patients in MAD and CTB as a post-operative seal dressing material for percutaneous interventions. Both the groups were graded for various efficacy parameters like comfort, applicability, dressing material, and immediate post-operative complications by operating doctor and attending nurse with a maximum 10 points in each group. Results: 120 patients were studied in each MAD and CTB group. Out of total patients 31.25% were males and the mean age of the patient was 33.56 ± 11.10. Allergic contact dermatitis developed in 9 (7.49%) of CTB group and in 1 (0.83%) of MAD group (P < 0.002), while local site skin infections were noted in 8 (6.67%) of CTB group and in 1 (0.83%) of MAD (P < 0.002). Operating doctor graded MAD and CTB to 7.60 ± 0.49 and 3.62 ± 0.48 (P < 0.003); and attending nurse 7.40 ± 0.49 and 3.41 ± 0.49 (P < 0.003) respectively. Conclusion: MAD is a safe, efficient and non-inferior alternative dressing material for post-procedure skin incision seal in comparison to CTB.

Published
2019

Catalog

Books, media, physical & digital resources
See catalog results